Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-09

FDA Approved: VASOPRESSIN — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for a generic vasopressin product from Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

ORIG AP for VASOPRESSIN (VASOPRESSIN)